
<HTML>
<HEAD>
<TITLE>IVAX CORPORATION FORM 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">





<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>

<DIV align="center" style="font-size: 12pt"><B>Washington, DC 20549</B>
</DIV>


<P align="center" style="font-size: 10pt"><HR align="center" size="1" noshade width="25%">


<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>


<P align="center" style="font-size: 10pt">CURRENT REPORT



<P align="center" style="font-size: 10pt">PURSUANT TO SECTION 13 OR 15(d) OF THE<BR>
SECURITIES EXCHANGE ACT OF 1934



<P align="center" style="font-size: 10pt"><HR align="center" size="1" noshade width="25%">



<P align="center" style="font-size: 10pt">Date of Report



<P align="center" style="font-size: 10pt"><B>December&nbsp;22, 2004</B><BR>
<HR align="center" size="1" noshade width="85%">


<DIV align="center" style="font-size: 10pt">(Date of earliest event reported)</DIV>


<P align="center" style="font-size: 24pt"><B>IVAX Corporation<BR>
<HR align="center" size="1" noshade width="85%"></B>


<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="85%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Florida</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>1-09623</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>16-1003559</B></TD>
</TR>

<TR style="font-size: 1px">
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of<BR>
incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(IRS Employer Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="85%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>4400 Biscayne Boulevard,<BR>
Miami, Florida</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><B>33127</B></TD>
</TR>

<TR style="font-size: 1px">
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom"><HR size="1" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of principal executive offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><B>(305)&nbsp;575-6000</B><BR>
<HR align="center" size="1" noshade width="85%">


<DIV align="center" style="font-size: 10pt">(Registrant&#146;s telephone number, including area code)</DIV>



<P align="center" style="font-size: 10pt"><B>Not Applicable</B><BR>
<HR align="center" size="1" noshade width="85%">


<DIV align="center" style="font-size: 10pt">(Former name or former address, if changed since last report)</DIV>


<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):



<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><FONT face="Wingdings">&#111;</FONT>&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>
</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><FONT face="Wingdings">&#111;</FONT>&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>
</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><FONT face="Wingdings">&#111;</FONT>&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))</TD>
</TR>
</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><FONT face="Wingdings">&#111;</FONT>&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e4(c) under the Exchange Act (17 CFR
240.13e-4(c))</TD>
</TR>
</TABLE>


<P>
<HR size="1" noshade color="#000000" style="margin-top: -2px">
<HR size="4" noshade color="#000000" style="margin-top: -10px">






<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">







<P align="left" style="font-size: 10pt"><B>Item&nbsp;1.01 Entry into a Material Definitive Agreement.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On December&nbsp;20, 2004, the Compensation Committee of the Board of Directors of IVAX Corporation
(the &#147;Company&#148;) accelerated the vesting of all of the Company&#146;s unvested stock options awarded to
officers and employees under the IVAX Corporation 1994 Stock Option Plan, the IVAX Corporation 1997
Stock Option Plan and the IVAX Corporation 2004 Incentive Compensation Plan which have an exercise
price greater than $15.39, the closing price of the Company&#146;s common stock on the American Stock
Exchange on December&nbsp;20, 2004. As a result of the acceleration, options to acquire approximately
8.2&nbsp;million shares of IVAX common stock (representing approximately 29% of the total outstanding
options), which otherwise would have vested from time to time over the next 46&nbsp;months, became
immediately exercisable. Approximately 65% of the accelerated options would have vested in any
event over the next 15&nbsp;months.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee&#146;s decision to accelerate the vesting of these options was in
response to the issuance by the Financial Accounting Standard Board of Statement of Financial
Accounting Standard No.&nbsp;123 (revised 2004) (&#147;FASB No.&nbsp;123R&#148;), &#147;Share-Based Payment.&#148; By
accelerating the vesting of these options, the Company believes it will potentially result in the
Company not being required to recognize any compensation expense in the current year or in future
periods associated with these options. However, there can be no assurance that the acceleration of
the options will avoid the recognition of compensation expense.


<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><B>Item&nbsp;2.03</B>&nbsp;</TD>
    <TD><B>Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant.</B></TD>
</TR>
</TABLE>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Item&nbsp;3.02 below.


<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><B>Item&nbsp;3.02.</B>&nbsp;</TD>
    <TD><B>Unregistered Sales of Equity Securities.</B></TD>
</TR>
</TABLE>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to a Purchase Agreement dated December&nbsp;17, 2004, the Company sold $333&nbsp;million of its
1.875% senior convertible notes due 2024 to qualified institutional buyers pursuant to Rule&nbsp;144A
under the Securities Act of 1933, as amended, on December&nbsp;22, 2004 at a cash purchase price of $985
per $1,000 initial principal amount of the notes. The notes were issued under an Indenture dated
December&nbsp;22, 2004 between the Company and U.S. Bank National Association, as trustee, and mature on
December&nbsp;15, 2024. On or after December&nbsp;15, 2010, the Company may redeem all or any part of the
notes at a redemption price equal to 100% of the principal amount of the notes to be redeemed. On
each of December&nbsp;15, 2010, December&nbsp;15, 2014 and December&nbsp;15, 2019, the holders may require the
Company to repurchase all or a portion of their notes. Holders of the notes may also require the
Company to repurchase their notes upon the occurrence of certain specified corporate transactions.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company received net proceeds of approximately $324.3&nbsp;million after deducting the initial
purchaser&#146;s discount and expenses of the offering. The Company used a portion of the net proceeds
towards the repurchase, in previously negotiated private transactions, of $250&nbsp;million principal
amount of its 4.5% convertible notes due 2008. Approximately $284&nbsp;million of the Company&#146;s 4.5%
convertible senior notes due 2008 remain outstanding. IVAX intends to use the remaining proceeds
for general corporate purposes.


<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under certain circumstances, the notes will be convertible into cash and, if applicable,
shares of the Company&#146;s common stock at an initial conversion rate of 48.1301 shares per $1,000
principal amount of these notes (equal to an initial conversion price of approximately $20.78 per
share), subject to adjustment. The notes are convertible prior to the stated maturity under the
following circumstances: (1)&nbsp;during any fiscal quarter (beginning with the quarter ending March
31, 2005) if the closing sale price of the Company&#146;s common stock for at least 20 consecutive
trading days in the 30 consecutive trading day period ending on the last trading day of the
immediately preceding fiscal quarter exceeds 120% of the conversion price on that 30th trading day;
(2)&nbsp;during any five consecutive trading day period immediately following any five consecutive
trading day period (the &#147;Note Measurement Period&#148;) in which the average market price for the notes
during that Note Measurement Period was less than 95% of the average conversion value for the notes
during such period; (3)&nbsp;if the Company calls the notes for redemption; or (4)&nbsp;upon the occurrence
of specified corporate transactions.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The aggregate value (the &#147;Conversion Value&#148;) of the cash and, if applicable, shares of common
stock per $1,000 principal amount of notes that will be received upon conversion by a holder of the
notes will be equal to the product of:


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">&#149;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the conversion rate then in effect; and</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">&#149;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the average of the daily volume-weighted average price per share of the Company&#146;s
common stock for each of the 10 consecutive trading days beginning on the second trading day
immediately following the day the notes are tendered for conversion (the &#147;10-day Weighted Average
Price&#148;).</TD>
</TR>

</TABLE>

<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will deliver the Conversion Value of the notes surrendered for conversion to
converting holders as follows:


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">&#149;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>a cash amount equal to the lesser of (1)&nbsp;the aggregate Conversion Value of the notes
to be converted and (2)&nbsp;the aggregate principal amount of the notes to be converted;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">&#149;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>if the aggregate Conversion Value of the notes to be converted is greater than the
Principal Return, an amount in whole shares equal to the quotient of (1)&nbsp;the aggregate Conversion
Value less the Principal Return and (2)&nbsp;the 10-day Weighted Average Price; and</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">&#149;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>a cash amount in lieu of any fractional shares of the Company&#146;s common stock.</TD>
</TR>

</TABLE>
<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


</TABLE>

<P align="center" style="font-size: 10pt"><U><B>SIGNATURES</B></U>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">IVAX CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Thomas E. Beier
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Thomas E. Beier&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Senior Vice President-Finance and
Chief Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt">Dated: December&nbsp;22, 2004




<P align="center" style="font-size: 10pt">3
</DIV>


</BODY>
</HTML>

